首页> 外文期刊>Diabetes research and clinical practice >Emerging parameters of the insulin and glucose response on the oral glucose tolerance test: Reproducibility and implications for glucose homeostasis in individuals with and without diabetes
【24h】

Emerging parameters of the insulin and glucose response on the oral glucose tolerance test: Reproducibility and implications for glucose homeostasis in individuals with and without diabetes

机译:口服葡萄糖耐量试验中胰岛素和葡萄糖反应的新兴参数:糖尿病患者和非糖尿病患者的葡萄糖稳态的重现性及其影响

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: Recent studies have suggested that novel parameters of the insulin and glucose response on the oral glucose tolerance test (OGTT) can provide metabolic insight beyond glucose tolerance, but have not evaluated their reproducibility. Thus, our aim was to evaluate the reproducibility of these parameters and, if confirmed, characterize their clinical/pathophysiologic relevance in healthy and diabetic individuals. Methods: Thirty healthy adults each underwent 3 replicate OGTTs, enabling assessment of the reproducibility of the following 5 parameters: time to insulin peak, shape of the glucose curve, glucose nadir below baseline, 1-h post-challenge glucose, and time to glucose peak. The only reproducible parameter was then further evaluated in 63 patients with early type 2 diabetes (T2DM) before and after 4-weeks of intensive insulin therapy (IIT) designed to improve beta-cell function (measured by Insulin Secretion-Sensitivity-Index-2 (ISSI-2)). Results: Of the five parameters, only time to glucose peak displayed reliable reproducibility on replicate testing (κ=0.76). Over 80% of controls had their glucose peak at 30-min post-load, whereas all but one of the diabetic patients had their peak at 60-min or later. ISSI-2 was lower in T2DM patients with peak at ≥90-min than in those with peak at ≤60-min (P=0.012). In patients in whom IIT improved beta-cell function by ≥20% from baseline, 39.1% had glucose peak on the post-therapy OGTT shift to an earlier timepoint, as compared to 15.4% with similar shift in those without such improvement(P=0.03). Conclusion: Time to glucose peak is a reproducible characteristic on the OGTT and associated with beta-cell function in early T2DM.
机译:目的:最近的研究表明,口服葡萄糖耐量试验(OGTT)上的胰岛素和葡萄糖反应的新参数可以提供超越葡萄糖耐量的代谢见解,但尚未评估其可重复性。因此,我们的目的是评估这些参数的可重复性,如果得到证实,则可以表征其在健康和糖尿病个体中的临床/病理生理相关性。方法:30名健康成年人每人接受3次OGTT重复试验,从而能够评估以下5个参数的再现性:胰岛素峰时间,葡萄糖曲线形状,基线以下葡萄糖最低点,挑战后1小时葡萄糖和葡萄糖时间峰。然后,对63个早期2型糖尿病(T2DM)患者在设计用于改善β细胞功能的强化胰岛素治疗(IIT)4周之前和之后进行了进一步的评估,其唯一可重现的参数(通过胰岛素分泌敏感性指数2进行测量) (ISSI-2))。结果:在这五个参数中,只有达到葡萄糖峰的时间才能在重复测试中显示出可靠的可重复性(κ= 0.76)。超过80%的对照者在负荷后30分钟的血糖峰值达到峰值,而除一名糖尿病患者外,所有糖尿病患者的血糖峰值均在60分钟或更晚。峰值≥90min的T2DM患者的ISSI-2低于峰值≤60min的患者(P = 0.012)。在IIT改善β细胞功能比基线提高20%以上的患者中,有39.1%的患者在治疗后OGTT转移到较早的时间点出现了葡萄糖峰值,而没有改善的患者中有15.4%的患者出现了类似的变化(P = 0.03)。结论:达到葡萄糖峰值的时间是OGTT的可再现特征,并且与早期T2DM中的β细胞功能有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号